Tesla Inc (TSLA.O) is building “RNA microfactories” for coronavirus vaccine developer CureVac in Germany, the electrical carmaker’s chief government officer, Elon Musk, tweeted on Wednesday.
CureVac, an unlisted German firm, has mentioned it is growing transportable, automated RNA manufacturing items that it calls printers. They shall be designed to be shipped to distant areas, the place they’ll churn out its vaccine candidate and different mRNA-based therapies relying on the recipe fed into the machine.
But for the fast pandemic use – ought to its vaccine candidate win market approval – it has manufacturing websites with regulatory approval in Germany with a capability to supply lots of of hundreds of thousands of doses.
It is additionally building a brand new stationary website that would improve its output tenfold to billions of doses.
Musk didn’t elaborate on his plans. Tesla and CureVac weren’t instantly obtainable to remark.
PreetiJha 
Vaibhav Kapoor